Email: info@allergy.org.au
Website: https://allergy.org.au

©2022 Australasian Society of Clinical Immunology and Allergy (ASCIA)
ABN 45 615 521 452

 

Immunodeficiency

Primary immunodeficiencies (PIDs), also known as inborn errors of immunity (IEI) are a group of more than 400 potentially serious disorders that can lead to frequent or severe infections, swellings and autoimmune problems. PID/IEI discorders can be caused by defects in genes that control the immune system, and may be inherited.  

Information for Health Professionals

ASCIA Position Statement - Immunoglobulin Replacement Therapy (IRT) in Primary Immunodeficiency (PID) Updated August 2022

ASCIA Immunodeficiency Strategy for Australia and New Zealand Launched May 2022

References - Immunodeficiency 

ASCIA Position Paper and Management Plan - Hereditary Angioedema (HAE) Updated January 2022

References - Hereditary Angioedema (HAE)

ASCIA Webinar - HAE

ASCIA Clinical Update - Primary Immunodeficiencies (PID) 

ASCIA Position Statement - Subcutaneous Immunoglobulin (SCIg) 

ASCIA Guide – Setting up a SCIg program in a hospital 

ASCIA Guidelines for Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in Australia and New Zealand: A TAPID Consensus Guideline

ASCIA Guidelines - Standardised IVIg Infusion Rates for IRT

ASCIA SCIg Treatment Plan 

ASCIA Transfer Care Plan for patients on IRT

ASCIA SCIg Checklists - Nurse Competency and Patient Training New May 2022

ASCIA Travel Plan for patients on SCIg 

ASCIA ID Register How to access information (available to Members Only)

Other health professional information is available here: www.allergy.org.au/hp/papers

Information for patients and carers is available here: www.allergy.org.au/patients/information 

Patient and carer support organisations are listed here: www.allergy.org.au/patients/patient-support-organisations

Content updated August 2022